{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:07:53Z","timestamp":1793959673872,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF2016R1A2B2013347"],"award-info":[{"award-number":["NRF2016R1A2B2013347"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760132"],"award-info":[{"award-number":["81760132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesangial cell proliferation has been identified as a major factor contributing to glomerulosclerosis, which is a typical symptom of diabetic nephropathy (DN). Lysophosphatidic acid (LPA) levels are increased in the glomerulus of the kidney in diabetic mice. LPA is a critical regulator that induces mesangial cell proliferation; however, its effect and molecular mechanisms remain unknown. The proportion of \u03b1-SMA<jats:sup>+<\/jats:sup>\/PCNA<jats:sup>+<\/jats:sup> cells was increased in the kidney cortex of <jats:italic>db\/db<\/jats:italic> mice compared with control mice. Treatment with LPA concomitantly increased the proliferation of mouse mesangial cells (SV40 MES13) and the expression of cyclin D1 and CDK4. On the other hand, the expression of p27<jats:sup>Kip1<\/jats:sup> was decreased. The expression of Kr\u00fcppel-like factor 5 (KLF5) was upregulated in the kidney cortex of <jats:italic>db\/db<\/jats:italic> mice and LPA-treated SV40 MES13 cells. RNAi-mediated silencing of KLF5 reversed these effects and inhibited the proliferation of LPA-treated cells. Mitogen-activated protein kinases (MAPKs) were activated, and the expression of early growth response 1 (Egr1) was subsequently increased in LPA-treated SV40 MES13 cells and the kidney cortex of <jats:italic>db\/db<\/jats:italic> mice. Moreover, LPA significantly increased the activity of the Ras-related C3 botulinum toxin substrate (Rac1) GTPase in SV40 MES13 cells, and the dominant-negative form of Rac1 partially inhibited the phosphorylation of p38 and upregulation of Egr1 and KLF5 induced by LPA. LPA-induced hyperproliferation was attenuated by the inhibition of Rac1 activity. Based on these results, the Rac1\/MAPK\/KLF5 signaling pathway was one of the mechanisms by which LPA induced mesangial cell proliferation in DN models.<\/jats:p>","DOI":"10.1038\/s12276-019-0217-3","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T07:02:39Z","timestamp":1550214159000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1\/MAPK\/KLF5 signaling"],"prefix":"10.1038","volume":"51","author":[{"given":"Donghee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Sin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Sook","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"217_CR1","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1056\/NEJMe1313104","volume":"369","author":"J Himmelfarb","year":"2013","unstructured":"Himmelfarb, J. & Tuttle, K. R. New therapies for diabetic kidney disease. N. Engl. J. Med. 369, 2549\u20132550 (2013).","journal-title":"N. Engl. J. Med."},{"key":"217_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4239\/wjd.v4.i6.245","volume":"4","author":"ML Gonzalez Suarez","year":"2013","unstructured":"Gonzalez Suarez, M. L., Thomas, D. B., Barisoni, L. & Fornoni, A. Diabetic nephropathy: is it time yet for routine kidney biopsy? World J. Diabetes 4, 245\u2013255 (2013).","journal-title":"World J. Diabetes"},{"key":"217_CR3","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1046\/j.1523-1755.2000.07710.x","volume":"77","author":"G Wolf","year":"2000","unstructured":"Wolf, G. Cell cycle regulation in diabetic nephropathy. Kidney Int. Suppl. 77, S59\u2013S66 (2000).","journal-title":"Kidney Int. Suppl."},{"key":"217_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3181\/0705-MR-134","volume":"233","author":"YS Kanwar","year":"2008","unstructured":"Kanwar, Y. S. et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood). 233, 4\u201311 (2008).","journal-title":"Exp. Biol. Med. (Maywood)."},{"key":"217_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1369\/0022155412465073","volume":"60","author":"SO Kolset","year":"2012","unstructured":"Kolset, S. O., Reinholt, F. P. & Jenssen, T. Diabetic nephropathy and extracellular matrix. J. Histochem. Cytochem. 60, 976\u2013986 (2012).","journal-title":"J. Histochem. Cytochem."},{"issue":"Suppl 1","key":"217_CR6","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1681\/ASN.2004110970","volume":"16","author":"FP Schena","year":"2005","unstructured":"Schena, F. P. & Gesualdo, L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 16(Suppl 1), S30\u2013S33 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.prostaglandins.2009.02.002","volume":"91","author":"ME Lin","year":"2010","unstructured":"Lin, M. E., Herr, D. R. & Chun, J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 91, 130\u2013138 (2010).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1042\/CS19980248","volume":"96","author":"CN Inoue","year":"1999","unstructured":"Inoue, C. N. et al. Lysophosphatidic acid and mesangial cells: implications for renal diseases. Clin. Sci. (Lond.) 96, 431\u2013436 (1999).","journal-title":"Clin. Sci. (Lond.)"},{"key":"217_CR9","doi-asserted-by":"publisher","first-page":"F1250","DOI":"10.1152\/ajprenal.00342.2003","volume":"287","author":"Y Xing","year":"2004","unstructured":"Xing, Y., Ganji, S. H., Noh, J. W. & Kamanna, V. S. Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth. Am. J. Physiol. Ren. Physiol. 287, F1250\u2013F1257 (2004).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"217_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ki.1997.143","volume":"51","author":"F Gaits","year":"1997","unstructured":"Gaits, F., Salles, J. P. & Chap, H. Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells. Kidney Int. 51, 1022\u20131027 (1997).","journal-title":"Kidney Int."},{"key":"217_CR11","doi-asserted-by":"publisher","first-page":"15541","DOI":"10.1074\/jbc.M700702200","volume":"282","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Kruppel-like factor 5. J. Biol. Chem. 282, 15541\u201315549 (2007).","journal-title":"J. Biol. Chem."},{"key":"217_CR12","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.M049189","volume":"55","author":"KJ Grove","year":"2014","unstructured":"Grove, K. J. et al. Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. J. Lipid Res. 55, 1375\u20131385 (2014).","journal-title":"J. Lipid Res."},{"key":"217_CR13","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00125-013-2891-3","volume":"56","author":"C Rancoule","year":"2013","unstructured":"Rancoule, C. et al. Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice. Diabetologia 56, 1394\u20131402 (2013).","journal-title":"Diabetologia"},{"key":"217_CR14","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.kint.2016.11.010","volume":"91","author":"HY Li","year":"2017","unstructured":"Li, H. Y., Oh, Y. S., Choi, J. W., Jung, J. Y. & Jun, H. S. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db\/db mice. Kidney Int. 91, 1362\u20131373 (2017).","journal-title":"Kidney Int."},{"key":"217_CR15","doi-asserted-by":"publisher","first-page":"F1138","DOI":"10.1152\/ajprenal.00315.2002","volume":"284","author":"K Sharma","year":"2003","unstructured":"Sharma, K., McCue, P. & Dunn, S. R. Diabetic kidney disease in the db\/db mouse. Am. J. Physiol. Ren. Physiol. 284, F1138\u2013F1144 (2003).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"217_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1681\/ASN.2004080648","volume":"16","author":"MD Breyer","year":"2005","unstructured":"Breyer, M. D. et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16, 27\u201345 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"217_CR17","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1159\/000088400","volume":"102","author":"CB Marshall","year":"2006","unstructured":"Marshall, C. B. & Shankland, S. J. Cell cycle and glomerular disease: a minireview. Nephron. Exp. Nephrol. 102, e39\u2013e48 (2006).","journal-title":"Nephron. Exp. Nephrol."},{"key":"217_CR18","doi-asserted-by":"publisher","first-page":"F515","DOI":"10.1152\/ajprenal.2000.278.4.F515","volume":"278","author":"SJ Shankland","year":"2000","unstructured":"Shankland, S. J. & Wolf, G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol. Ren. Physiol. 278, F515\u2013F529 (2000).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"217_CR19","doi-asserted-by":"publisher","first-page":"17685","DOI":"10.18632\/oncotarget.3779","volume":"6","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1. Oncotarget 6, 17685\u201317697 (2015).","journal-title":"Oncotarget"},{"key":"217_CR20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ijc.21533","volume":"118","author":"C Chen","year":"2006","unstructured":"Chen, C. et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int. J. Cancer 118, 1346\u20131355 (2006).","journal-title":"Int. J. Cancer"},{"key":"217_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/01.RES.85.9.787","volume":"85","author":"K Kawai-Kowase","year":"1999","unstructured":"Kawai-Kowase, K., Kurabayashi, M., Hoshino, Y., Ohyama, Y. & Nagai, R. Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. Circ. Res. 85, 787\u2013795 (1999).","journal-title":"Circ. Res."},{"key":"217_CR22","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1016\/j.biochi.2012.05.023","volume":"94","author":"W Windischhofer","year":"2012","unstructured":"Windischhofer, W. et al. LPA-induced suppression of periostin in human osteosarcoma cells is mediated by the LPA(1)\/Egr-1 axis. Biochimie 94, 1997\u20132005 (2012).","journal-title":"Biochimie"},{"key":"217_CR23","doi-asserted-by":"publisher","first-page":"22635","DOI":"10.1074\/jbc.M111.335695","volume":"287","author":"T Iyoda","year":"2012","unstructured":"Iyoda, T. et al. Lysophosphatidic acid induces early growth response-1 (Egr-1) protein expression via protein kinase Cdelta-regulated extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activation in vascular smooth muscle cells. J. Biol. Chem. 287, 22635\u201322642 (2012).","journal-title":"J. Biol. Chem."},{"key":"217_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ncb0806-781","volume":"8","author":"K Burridge","year":"2006","unstructured":"Burridge, K. & Doughman, R. Front and back by Rho and Rac. Nat. Cell Biol. 8, 781\u2013782 (2006).","journal-title":"Nat. Cell Biol."},{"key":"217_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0092-8674(04)00003-0","volume":"116","author":"K Burridge","year":"2004","unstructured":"Burridge, K. & Wennerberg, K. Rho and Rac take center stage. Cell 116, 167\u2013179 (2004).","journal-title":"Cell"},{"key":"217_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1159\/000107758","volume":"27","author":"K Ichinose","year":"2007","unstructured":"Ichinose, K., Kawasaki, E. & Eguchi, K. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am. J. Nephrol. 27, 554\u2013564 (2007).","journal-title":"Am. J. Nephrol."},{"key":"217_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1046\/j.1523-1755.1999.00590.x","volume":"56","author":"G Wolf","year":"1999","unstructured":"Wolf, G. & Ziyadeh, F. N. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56, 393\u2013405 (1999).","journal-title":"Kidney Int."},{"key":"217_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/CS20000293","volume":"101","author":"CN Inoue","year":"2001","unstructured":"Inoue, C. N. et al. Bimodal effects of platelet-derived growth factor on rat mesangial cell proliferation and death, and the role of lysophosphatidic acid in cell survival. Clin. Sci. (Lond.) 101, 11\u201319 (2001).","journal-title":"Clin. Sci. (Lond.)"},{"key":"217_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/1097-0215(20010720)95:4<209::AID-IJC1036>3.0.CO;2-R","volume":"95","author":"Y Dong","year":"2001","unstructured":"Dong, Y., Sui, L., Sugimoto, K., Tai, Y. & Tokuda, M. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas. Int. J. Cancer 95, 209\u2013215 (2001).","journal-title":"Int. J. Cancer"},{"key":"217_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0962-8924(02)00043-0","volume":"13","author":"O Coqueret","year":"2003","unstructured":"Coqueret, O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13, 65\u201370 (2003).","journal-title":"Trends Cell Biol."},{"key":"217_CR31","first-page":"3689","volume":"60","author":"CJ Sherr","year":"2000","unstructured":"Sherr, C. J. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689\u20133695 (2000).","journal-title":"Cancer Res."},{"key":"217_CR32","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/ndt\/gfu202","volume":"29","author":"F Liu","year":"2014","unstructured":"Liu, F. et al. The effect of FoxO1 on the proliferation of rat mesangial cells under high glucose conditions. Nephrol. Dial. Transplant. 29, 1879\u20131887 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"217_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1248\/bpb.34.967","volume":"34","author":"B Wang","year":"2011","unstructured":"Wang, B. et al. Bufalin inhibits platelet-derived growth factor-BB-induced mesangial cell proliferation through mediating cell cycle progression. Biol. Pharm. Bull. 34, 967\u2013973 (2011).","journal-title":"Biol. Pharm. Bull."},{"key":"217_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/08860220903491240","volume":"32","author":"D Kumar","year":"2010","unstructured":"Kumar, D. et al. Heme oxygenase-1 modulates mesangial cell proliferation by p21 Waf1 upregulation. Ren. Fail. 32, 254\u2013258 (2010).","journal-title":"Ren. Fail."},{"issue":"3 Pt 2","key":"217_CR35","first-page":"F348","volume":"273","author":"G Wolf","year":"1997","unstructured":"Wolf, G. et al. High glucose stimulates expression of p27Kip1 in cultured mouse mesangial cells: relationship to hypertrophy. Am. J. Physiol. 273(3 Pt 2), F348\u2013F356 (1997).","journal-title":"Am. J. Physiol."},{"key":"217_CR36","doi-asserted-by":"publisher","first-page":"e0123724","DOI":"10.1371\/journal.pone.0123724","volume":"10","author":"D Gao","year":"2015","unstructured":"Gao, D. et al. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells. PLoS ONE 10, e0123724 (2015).","journal-title":"PLoS One"},{"key":"217_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2337\/diab.46.5.847","volume":"46","author":"M Haneda","year":"1997","unstructured":"Haneda, M. et al. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46, 847\u2013853 (1997).","journal-title":"Diabetes"},{"key":"217_CR38","first-page":"S66","volume":"60","author":"M Haneda","year":"1997","unstructured":"Haneda, M. et al. Activation of mitogen-activated protein kinase cascade in diabetic glomeruli and mesangial cells cultured under high glucose conditions. Kidney Int. Suppl. 60, S66\u2013S69 (1997).","journal-title":"Kidney Int. Suppl."},{"key":"217_CR39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1159\/000430177","volume":"36","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Transcription factor Egr1 is involved in high glucose-induced proliferation and fibrosis in rat glomerular mesangial cells. Cell. Physiol. Biochem. 36, 2093\u20132107 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"217_CR40","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1089\/104303400750001444","volume":"11","author":"M Bryant","year":"2000","unstructured":"Bryant, M. et al. Tissue repair with a therapeutic transcription factor. Hum. Gene Ther. 11, 2143\u20132158 (2000).","journal-title":"Hum. Gene Ther."},{"key":"217_CR41","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1092053","volume":"302","author":"AJ Ridley","year":"2003","unstructured":"Ridley, A. J. et al. Cell migration: integrating signals from front to back. Science 302, 1704\u20131709 (2003).","journal-title":"Science"},{"key":"217_CR42","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1172\/JCI43124","volume":"121","author":"S Shibata","year":"2011","unstructured":"Shibata, S. et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J. Clin. Invest. 121, 3233\u20133243 (2011).","journal-title":"J. Clin. Invest."},{"key":"217_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00240-011-0405-7","volume":"40","author":"V Thamilselvan","year":"2012","unstructured":"Thamilselvan, V., Menon, M. & Thamilselvan, S. Selective Rac1 inhibition protects renal tubular epithelial cells from oxalate-induced NADPH oxidase-mediated oxidative cell injury. Urol. Res. 40, 415\u2013423 (2012).","journal-title":"Urol. Res."},{"key":"217_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3109\/0886022X.2013.764256","volume":"35","author":"M Gumustekin","year":"2013","unstructured":"Gumustekin, M. et al. The effect of insulin treatment on Rac1 expression in diabetic kidney. Ren. Fail. 35, 396\u2013402 (2013).","journal-title":"Ren. Fail."},{"key":"217_CR45","doi-asserted-by":"publisher","first-page":"F1316","DOI":"10.1152\/ajprenal.00345.2009","volume":"297","author":"SC Hubchak","year":"2009","unstructured":"Hubchak, S. C., Sparks, E. E., Hayashida, T. & Schnaper, H. W. Rac1 promotes TGF-beta-stimulated mesangial cell type I collagen expression through a PI3K\/Akt-dependent mechanism. Am. J. Physiol. Ren. Physiol. 297, F1316\u2013F1323 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"217_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1074\/jbc.M210151200","volume":"278","author":"FN Van Leeuwen","year":"2003","unstructured":"Van Leeuwen, F. N. et al. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J. Biol. Chem. 278, 400\u2013406 (2003).","journal-title":"J. Biol. Chem."},{"key":"217_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0353-z","volume":"9","author":"Z Lv","year":"2018","unstructured":"Lv, Z. et al. Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice. Cell Death Dis. 9, 342 (2018).","journal-title":"Cell Death Dis."},{"key":"217_CR48","doi-asserted-by":"publisher","first-page":"e80328","DOI":"10.1371\/journal.pone.0080328","volume":"8","author":"A Babelova","year":"2013","unstructured":"Babelova, A. et al. Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease. PLoS ONE 8, e80328 (2013).","journal-title":"PLoS One"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0217-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0217-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T22:03:17Z","timestamp":1650146597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0217-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0217-3","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"29 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}